tiprankstipranks
Sana Biotechnology (SANA)
NASDAQ:SANA
US Market

Sana Biotechnology (SANA) Financial Statements

225 Followers

Sana Biotechnology Financial Overview

Sana Biotechnology's market cap is currently ―. The company's EPS TTM is $-1.528; its P/E ratio is -3.42; Sana Biotechnology is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -69.47M$ -74.45M$ -164.25M$ -60.64M$ -84.10M
EBITDA$ -62.38M$ -59.95M-$ -52.75M$ -76.44M
Net Income Common Stockholders$ -107.47M$ -88.12M$ -164.25M$ -114.00M$ -82.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 311.08M$ 205.19M$ 268.57M$ 332.01M$ 355.41M
Total Assets$ 681.38M$ 565.30M$ 631.44M$ 707.15M$ 746.93M
Total Debt$ 106.09M$ 104.10M$ 96.86M$ 113.14M$ 114.50M
Net Debt$ -204.99M$ -101.10M$ -171.71M$ -218.88M$ -240.91M
Total Liabilities$ 306.24M$ 277.79M$ 265.59M$ 352.12M$ 318.67M
Stockholders Equity$ 375.14M$ 287.51M$ 365.85M$ 355.03M$ 428.26M
Cash Flow-
Free Cash Flow$ -81.48M$ -66.00M-$ -54.87M$ -86.95M
Operating Cash Flow$ -65.63M$ -51.96M$ -63.55M$ -53.30M$ -84.78M
Investing Cash Flow$ -77.23M$ 15.31M$ 51.35M$ 37.17M$ 68.19M
Financing Cash Flow$ 186.40M$ 1.72M$ 187.00K$ 29.50M$ 236.00K
Currency in USD

Sana Biotechnology Earnings and Revenue History

Sana Biotechnology Debt to Assets

Sana Biotechnology Cash Flow

Sana Biotechnology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis